Advertisement
Advertisement

OPK

OPK logo

Opko Health Inc.

1.23
USD
Sponsored
-0.01
-1.20%
Feb 05, 15:59 UTC -5
Closed
exchange

Pre-Market

1.24

+0.01
+0.81%

OPK Earnings Reports

Positive Surprise Ratio

OPK beat 20 of 40 last estimates.

50%

Next Report

Date of Next Report
Feb 19, 2026
Estimate for Q4 25 (Revenue/ EPS)
$141.15M
/
-$0.06
Implied change from Q3 25 (Revenue/ EPS)
-6.95%
/
-300.00%
Implied change from Q4 24 (Revenue/ EPS)
-23.12%
/
-700.00%

Opko Health Inc. earnings per share and revenue

On Oct 29, 2025, OPK reported earnings of 0.03 USD per share (EPS) for Q3 25, beating the estimate of -0.04 USD, resulting in a 165.93% surprise. Revenue reached 151.70 million, compared to an expected 162.39 million, with a -6.58% difference. The market reacted with a +2.10% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 8 analysts forecast an EPS of -0.06 USD, with revenue projected to reach 141.15 million USD, implying an decrease of -300.00% EPS, and decrease of -6.95% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

logo
Mesa Laboratories Inc
Report Date
Feb 03, 2026 For Q3 26
Estimate
$0.28
Actual
$3.07
Surprise
+987.88%
logo
Accuray Incorporated
Report Date
Feb 04, 2026 For Q2 26
Estimate
-$0.11
Actual
-$0.11
Surprise
+1.96%
logo
Thermo Fisher Scientific, Inc.
Report Date
Jan 29, 2026 For Q4 25
Estimate
$6.51
Actual
$6.57
Surprise
+0.91%
logo
Idexx Laboratories Inc
Report Date
Feb 02, 2026 For Q4 25
Estimate
$2.98
Actual
$3.08
Surprise
+3.12%
logo
IQVIA Holdings Inc.
Report Date
Feb 05, 2026 For Q4 25
Estimate
$3.43
Actual
$3.42
Surprise
-0.34%
logo
Mettler-Toledo International
Report Date
Feb 05, 2026 For Q4 25
Estimate
$12.92
Actual
$13.36
Surprise
+3.34%
logo
STERIS plc
Report Date
Feb 04, 2026 For Q3 26
Estimate
$2.55
Actual
$2.52
Surprise
-0.99%
logo
Hologic Inc
Report Date
Jan 29, 2026 For Q1 26
Estimate
$1.11
Actual
$1.04
Surprise
-6.45%
FAQ
For Q3 2025, Opko Health Inc. reported EPS of $0.03, beating estimates by 165.93%, and revenue of $151.70M, -6.58% below expectations.
The stock price moved up 2.1%, changed from $1.43 before the earnings release to $1.46 the day after.
The next earning report is scheduled for Feb 19, 2026.
Based on 8 analysts, Opko Health Inc. is expected to report EPS of -$0.06 and revenue of $141.15M for Q4 2025.
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement